Rongxin Chen

424 citations
15 papers · 321 indexed · h-index 10
Topics
Cancer Research and Treatments (3 papers)Hepatocellular Carcinoma Treatment and Prognosis (3 papers)Bone and Dental Protein Studies (3 papers)
Partner nations
ChinaEthiopiaIndia

In The Last Decade

Rongxin Chen

15 papers receiving 317 citations

Peers

Rongxin Chen
Comparison fields: 5 of 71
  • Molecular Biology 145
  • Epidemiology 80
  • Cancer Research 71
  • Oncology 57
  • Hepatology 38
Replace Young‐Kook Choi with:
Young‐Kook Choi United States
Nelly Youssef France
Min Deng China
Zhiqun Tang China
Zhaojie Lyu China
Xin Tian China
Jianxin Wu China
Bjørk Ditlev Larsen Denmark
Anna U. Newlaczyl United Kingdom
Eric Lo United States
Rongxin Chen relative to Young‐Kook Choi United States Young‐Kook Choi's profile →
Citations per field
00.5×5.3×
Young‐Kook Choi · 1×
Citations per year

Countries citing papers authored by Rongxin Chen

Since Specialization
Citations

This map shows the geographic impact of Rongxin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongxin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongxin Chen more than expected).

Fields of papers citing papers by Rongxin Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongxin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongxin Chen. The network helps show where Rongxin Chen may publish in the future.

Co-authorship network of co-authors of Rongxin Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Rongxin Chen. A scholar is included among the top collaborators of Rongxin Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongxin Chen. Rongxin Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 4
2 7
3 21
4 60
5 40
6 8
7 12
8 4
9 32
10
[Central venous-to-arterial carbon dioxide difference in critically ill pediatric patients with septic shock].
5
11 24
12 25
13 31
14 26
15 22

About Rongxin Chen

Rongxin Chen is a scholar working on Hepatology, Biotechnology and Physiology, having authored 15 papers that have together received 321 indexed citations. Recurring topics across this work include Cancer Research and Treatments (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Bone and Dental Protein Studies (3 papers). The work is most often cited by research in Hepatology (38 citations), Cancer Research (71 citations) and Rheumatology (35 citations). Rongxin Chen has collaborated with scholars based in China, Ethiopia and India. Frequent co-authors include Xiahui Lin, Rui Zhang, Jiefeng Cui, Sheng‐Long Ye, Tong‐Chun Xue, Dongmei Gao, Zhenggang Ren, Min Ma, Shu-Jung Hsu and Jun Chen. Their work appears in journals such as JAMA, Medicine and Environmental Science and Pollution Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026